Acquired hemophilia A: case report

Czech version

Authors: Štefan Sotak ¹; Miriam Mitníková ²
Authors‘ workplace: I. interná klinika LF UPJŠ a UN L. Pasteura Košice, Slovenská republika ¹; Oddelenie labortórnej medicíny LF UPJŠ a UN L. Pasteura Košice, Slovenská republika ²
Published in: Vnitř Lék 2018; 64(4): 427-431
Category: Case Reports

Overview

Case report of a 74-year-old male with acquired hemophilia A, whose etiology was not found, confirmed by hemocoagulation examinations, with clinical manifestation of protracted macroscopic hematuria, spontaneous skin and intramuscular bleedings. Treatment comprised conservative therapy administration of hemostyptics, red blood cells transfusions application of recombinant human factor VII (rFVII) and immunosuppression. Finally, patient died due to nosocomial infection caused by multidrug-resistant pulmonary pathogen.

Key words:
acquired hemophilia A –⁠ bleeding

Sources

1. Theodossiades G, Kontopoulou-Griva I. Acquired haemophilia A. Haema 2002; 5 : 282–290.

2. Franchini M, Castaman G, Coppola A et al. Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management. Blood Transfus 2015; 13(3): 498–513. Dostupné z DOI: <http://dx.doi.org/10.2450/2015.0141–15>.

3. Bainton R, Makris M. The diagnosis and management of acquired hemophilia. CME Bulletin Haematology 2000; 3(1): 3–5.

4. Baudo F, De Cataldo F. Acquired hemophilia: a critical bleeding syndrome. Haematologica 2004; 89(1): 96–100.

5. Collins P, Macartney N, Davies R et al. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J of Haemathol 2004; 124(1): 86–90.

6. Collins PW, Percy CL. Advances in the understanding of acquired haemophilia A: implications for clinical practice. Br J Haematol 2010; 148(2): 183–194. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365–2141.2009.07915.x>.

7. Bona D, Schiavoni M, Castaman G et al. Acquired hemophilia: experience of two Italian centres with 27 new cases. Haemophilia 1997; 3(3): 183–188. Dostupné z DOI: <http://dx.doi.org/10.1046/j.1365–2516.1997.00102.x>.

8. Collins PW, Hirsch S, Baglin TP et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctor’ Organisation. Blood 2007; 109(5): 1870–1877. Dostupné z DOI: <http://dx.doi.org/10.1182/blood-2006–06–029850>.

9. Knöbl P, Marco P, Baudo F et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 2012; 10(4): 622–631. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1538–7836.2012.04654.x>.

10. Borg JY, Guillet B, Le Cam-Duchez V et al. Outcome of acquired haemophilia in France: the prospective SACHA. Haemophilia 2013; 19(4): 564–570. Dostupné z DOI: <http://dx.doi.org/10.1111/hae.12138>.

11. Tiede A, Klamroth R, Scharf RE et al. Prognostic factors for remission of and survival in acquired hemophilia A: results from the GTH-AH 01/2010 study. Blood 2015; 125(7): 1091–1097. Dostupné z DOI: <http://dx.doi.org/10.1182/blood-2014–07–587089>.

12. Mansouritorghabeh H. Clinical and Laboratory Approaches to Hemophilia A. Iran J Med Sci 2015; 40(3): 194–205.

13. Buliková A, Smejkal P, Zavřelová J et al. Získané inhibitory krevního srážení. Interní Med 2008; 10(7–8): 336–339.

14. Sániová B. Použitie rekombinantného faktora VIIa počas masívnych tehotenských krvácaní. Vask Med 2016; 8(3): 107–109.

15. Hay CR, Baglin TP, Collins PW et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors‘ Organization (UKHCDO). Br J Haemathol 2000; 111(1): 78–90.

16. Collins PW. Management of acquired haemophilia A –⁠ more questions than answers. Blood Coagul Fibrinolysis 2003; 14(Suppl 1): S23-S27.

17. Tengborn L, Ingerslev J, Mäkipernaa A et al. Acquired haemophilia. Nordic guidelines for diagnosis and treatment, version 2006. Dostupné z DOI: <http://www.hematology.fi/sites/default/files/uploads/nordic_hemophilia_guidelines_final_20150623.pdf>.

18. Kubisz P, Staško J, Hollý P. Získaná hemofília A. Inter Med 2005; 5(12): 702–706.

19. Karimi M, Abdolkarimi B, Majid N et al. Acquired Hemophilia: A Report of 4 Cases. Ann Hematol Oncol 2016; 3(1): 1074.

20. Kershaw G, Favaloro EJ. Laboratory identification of factor inhibitors: an update. Pathology 2012; 44(4): 293–302. Dostupné z DOI: <http://dx.doi.org/10.1097/PAT.0b013e328353254d>.